Found: 5
Select item for more details and to access through your institution.
Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2019, v. 28, n. 8, p. 1035, doi. 10.1002/pds.4785
- By:
- Publication type:
- Article
Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician.
- Published in:
- Current Rheumatology Reports, 2017, v. 19, n. 6, p. 1, doi. 10.1007/s11926-017-0658-4
- By:
- Publication type:
- Article
Differentiating biosimilarity and comparability in biotherapeutics.
- Published in:
- Clinical Rheumatology, 2016, v. 35, n. 12, p. 2877, doi. 10.1007/s10067-016-3427-2
- By:
- Publication type:
- Article
Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology.
- Published in:
- Rheumatology International, 2016, v. 36, n. 5, p. 613, doi. 10.1007/s00296-016-3444-0
- By:
- Publication type:
- Article